IP Library Granted Patent US 8,417,343
Granted Patent B2
US 8,417,343 · App. 11/907,533 · Granted Apr 9, 2013

Obstructive sleep apnea treatment devices, systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,417,343
App. No.
11/907,533
Granted
Apr 9, 2013
Kind
B2
Abstract

Devices, systems and methods for nerve stimulation for OSA therapy.

Claims (28)

1. A method of treating obstructive sleep apnea, the method comprising:

chronically implanting an electrode on a nerve innervating an upper airway dilator muscle;

sensing a measure of respiration;

analyzing the measure of respiration to identify onsets of expiration;

calculating a respiratory period from the onsets of expiration;

predicting the onset of a future expiratory phase; and

beginning stimulation of the nerve a fraction of the calculated respiratory period before the onset of the future expiratory phase, and continuing stimulation of the nerve during an entire inspiratory phase, wherein the method is performed without identifying an onset of the inspiratory phase.

2. The method of claim 1 , wherein the fraction ranges between 30/100 and 50/100.

3. The method of claim 1 , wherein the fraction is selectively adjustable.

4. The method of claim 1 , wherein the measure of respiration is bio-impedance.

5. The method of claim 1 , wherein the electrode is disposed on a nerve cuff operably connected to a first end of a stimulation lead.

6. The method of claim 5 , wherein a second end of the stimulation lead is operably connected to a neurostimulator.

7. The method of claim 6 , wherein the neurostimulator is operably connected to a respiration sensing lead having a proximal end and a distal portion, wherein the distal portion is connected to a respiration sensor.

8. The method of claim 6 , wherein the neurostimulator includes electronics containing an algorithm.

9. The method of claim 8 , wherein the algorithm triggers the delivery of the stimulation via the stimulation lead.

10. The method of claim 5 , wherein the stimulation lead includes a sigmoid-shaped section.

11. The method of claim 5 , wherein the nerve cuff is cylindrical and includes a first semi-cylindrical portion connected to a second semi-cylindrical portion.

12. The method of claim 11 , wherein the first semi-cylindrical portion is shorter in length than the second semi-cylindrical portion.

13. The method of claim 5 , wherein the nerve cuff is cylindrical and includes a semi-cylindrical portion having a plurality of extending semi-cylindrical arms having free ends.

14. The method of claim 5 , wherein the nerve cuff includes a plurality of electrodes configured to steer an electrical field.

15. A method of treating obstructive sleep apnea, the method comprising:

obtaining a respiration waveform;

analyzing the respiration waveform to identify onsets of expiration;

calculating a respiratory period from the onsets of expiration;

predicting the onset of a future expiratory phase; and

stimulating a nerve to cause dilation of a patient's upper airway, wherein stimulation of the nerve begins a fraction of the calculated respiratory cycle period before the onset of the future expiratory phase, and continuing stimulation of the nerve during an entire inspiratory phase, wherein the method is performed without identifying an onset of the inspiratory phase.

16. The method of claim 15 , wherein the fraction is selectively adjustable.

17. The method of claim 15 , wherein analyzing the respiration waveform to identify onsets of expiration includes identifying a peak of the respiration waveform.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
CHANGE OF NAME Recorded Aug 20, 2019
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 050106/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2014
From: APNEX MEDICAL, INC.
To: CYBERONICS, INC.
Reel/Frame 032244/0509 →
SECURITY AGREEMENT Recorded Oct 17, 2012
From: APNEX MEDICAL, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP
Reel/Frame 029141/0956 →